MYL has pretty good protection from TEVA’s hostile offer thanks to a poison pill it implemented under Dutch corporate law, which transfers responsibility for approving a merger to a foundation.
(MYL became a Dutch-domiciled company when it acquired ABT’s European branded-generics business; #msg-110385639.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.